FDA Approves Daiichi Sankyos TURALIO pexidartinib for the Treatment of Select Patients with TGCT a Rare and Debilitating Tumor
Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIO as the first and only treatment for adult patients with symptomatic TGCT associated...
GlycoMimetics Reports Top-line Results From Pfizers Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease
GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal study did...
GSK grants exclusive technology license for clinical stage Ebola vaccines to Sabin Vaccine Institute
GSK and the Sabin Vaccine Institute announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola...
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) in Shanghai and active...
CURE Pharmaceutical Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
CURE Pharmaceutical, an innovative drug delivery and development company, announced the allowance of U.S. Application No. 15/666,057, which covers edible thin films with natural...
Boehringer Ingelheim Expands IPF Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
Boehringer Ingelheim and Bridge Biotherapeutics Inc. announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge...
Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data
Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial for type-1 diabetes is advancing with additional patients for...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...